InsiderSignalSign in
← Insider buys

Jeffrey Hessekiel has sold EXEL and made no open-market buys since Mar 2017

EVP and General Counsel at Exelixis, Inc.

SEC CIK 0001599803 · Filings on SEC.gov ↗

$0Bought
$24.8MSold
NoneLast buy

Every filing

29 filings since Mar 2017, newest first

EXELSell

Exelixis, Inc.

EVP and General Counsel

$1.7M−9.0%Nov 5
EXELSell

Exelixis, Inc.

EVP and General Counsel

$710K−4.0%Oct 30
EXELSell

Exelixis, Inc.

EVP and General Counsel

$660K−4.0%Sep 25
EXELSell

Exelixis, Inc.

EVP, GC, Sec

$516K−3.0%Aug 28
EXELSell

Exelixis, Inc.

EVP, GC, Sec

$2.1M−11.0%Aug 9
EXELSell

Exelixis, Inc.

EVP, GC, Sec

$575K−4.0%Dec 14
EXELSell

Exelixis, Inc.

EVP, GC, Sec

$1.1M−8.0%Dec 4
EXELSell

Exelixis, Inc.

EVP, GC, Sec

$1.1M−9.0%Aug 3
EXELSell

Exelixis, Inc.

EVP, GC, Sec

$779K−6.0%Apr 5
EXELSell

Exelixis, Inc.

EVP, GC, Sec

$1.3M−13.0%Mar 3
EXELSell

Exelixis, Inc.

EVP, GC, Sec

$818K−6.0%Nov 17
EXELSell

Exelixis, Inc.

EVP, GC, Sec

$396K−3.0%Mar 30
EXELSell

Exelixis, Inc.

EVP and General Counsel

$360K−3.0%Feb 28
EXELSell

Exelixis, Inc.

EVP and General Counsel

$113K−1.0%Nov 3
EXELSell

Exelixis, Inc.

EVP and General Counsel

$284K−2.0%Oct 15
EXELSell

Exelixis, Inc.

EVP and General Counsel

$451K−3.0%Apr 28
EXELSell

Exelixis, Inc.

EVP and General Counsel

$872K−10.0%Oct 23
EXELSell

Exelixis, Inc.

EVP and General Counsel

$268K−3.0%Sep 24
EXELSell

Exelixis, Inc.

EVP and General Counsel

$522K−5.0%Sep 16
EXELSell

Exelixis, Inc.

EVP and General Counsel

$2.4M−28.0%May 11
EXELSell

Exelixis, Inc.

EVP and General Counsel

$1.6M−24.0%Aug 20
EXELSell

Exelixis, Inc.

EVP and General Counsel

$481K−8.0%Apr 3
EXELSell

Exelixis, Inc.

EVP and General Counsel

$285K−6.0%Nov 30
EXELSell

Exelixis, Inc.

EVP and General Counsel

$1.3M−20.0%Jun 1
EXELSell

Exelixis, Inc.

EVP and General Counsel

$447K−6.0%May 7
EXELSell

Exelixis, Inc.

EVP and General Counsel

$663K−9.0%Sep 28
EXELSell

Exelixis, Inc.

EVP and General Counsel

$145K−3.0%Mar 28
EXELSell

Exelixis, Inc.

EVP and General Counsel

$489K−8.0%Mar 24
EXELSell

Exelixis, Inc.

EVP and General Counsel

$2.3M−29.0%Mar 7
About Jeffrey Hessekiel

Jeffrey Hessekiel is a person and a seasoned biopharmaceutical legal executive. He served as Executive Vice President and General Counsel at Exelixis from February 2014 to 2025, where he led the company’s legal, intellectual property, compliance, GxP quality, and government affairs/policy functions; he later joined Cytokinetics in November 2025 as Executive Vice President, Chief Legal & Administrative Officer.(

Earlier in his career, Hessekiel held legal and compliance roles at Gilead Sciences from 2002 to 2012, ultimately serving as Chief Compliance & Quality Officer, and he also practiced corporate law at Wilson Sonsini Goodrich & Rosati and Heller Ehrman after serving as senior counsel at Arnold & Porter.( He earned a B.A. in Political Science from Duke University and a J.D., cum laude, from The George Washington University Law School; he also completed a Diploma in International Commercial Arbitration at Keble College, Oxford University.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.